Clinical Trial Update: Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for jaktinib in moderate to severe atopic dermatitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED